Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma

BACKGROUND: Outcome in multiple myeloma (MM) has improved substantially over recent years as a result of the availability of multiple novel agents with acceptable safety profile. STUDY DESIGN: Prospective observational study at a tertiary care institute. METHODS: Twenty-five newly diagnosed patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan Zafar, Mir Sadaqat, Khan, Afaq Ahmed, Aggarwal, Shyam, Bhargava, Manorama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865101/
https://www.ncbi.nlm.nih.gov/pubmed/29600238
http://dx.doi.org/10.4103/sajc.sajc_59_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865101/
https://www.ncbi.nlm.nih.gov/pubmed/29600238
http://dx.doi.org/10.4103/sajc.sajc_59_17

Ejemplares similares